BBC holdings
Virtus Biotech Clinical Trials ETF
Positions
132 stored of 132 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DREYFUS GOVERNMENT CASH MANAGE | Not reported | Not reported | 3.476% | $1.6M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 2 | FIRST TRACKS BIOTHERAPEUTICS INC FIRST TRACKS BIOTHERAPEUTICS INC ORD SHS | US3371851029 | 337185102 | 1.673% | $776K | Equity (common) | Corporate | United States | USD |
| 3 | MBX BIOSCIENCES INC MBX BIOSCIENCES INC COM | US55287L1017 | 55287L101 | 1.244% | $577K | Equity (common) | Corporate | United States | USD |
| 4 | ATAIBECKLEY INC ATAIBECKLEY INC COM SHS | US04650F1012 | 04650F101 | 1.227% | $569K | Equity (common) | Corporate | United States | USD |
| 5 | MONOPAR THERAPEUTICS INC MONOPAR THERAPEUTICS INC COM NEW | US61023L2079 | 61023L207 | 1.214% | $563K | Equity (common) | Corporate | United States | USD |
| 6 | DEFINIUM THERAPEUTICS INC DEFINIUM THERAPEUTICS INC COM SHS | CA24477V1058 | 24477V105 | 1.178% | $547K | Equity (common) | Corporate | Canada | USD |
| 7 | XENCOR INC XENCOR INC COM | US98401F1057 | 98401F105 | 1.098% | $509K | Equity (common) | Corporate | United States | USD |
| 8 | ZENAS BIOPHARMA INC ZENAS BIOPHARMA INC COM | US98937L1052 | 98937L105 | 1.064% | $494K | Equity (common) | Corporate | United States | USD |
| 9 | UNIQURE NV UNIQURE NV SHS | NL0010696654 | Not reported | 1.060% | $492K | Equity (common) | Corporate | Netherlands | USD |
| 10 | APOGEE THERAPEUTICS INC APOGEE THERAPEUTICS INC COM | US03770N1019 | 03770N101 | 1.017% | $472K | Equity (common) | Corporate | United States | USD |
| 11 | VOR BIOPHARMA INC VOR BIOPHARMA INC COM NEW | US9290332074 | 929033207 | 0.987% | $458K | Equity (common) | Corporate | United States | USD |
| 12 | REGENXBIO INC REGENXBIO INC COM | US75901B1070 | 75901B107 | 0.975% | $452K | Equity (common) | Corporate | United States | USD |
| 13 | LB PHARMACEUTICALS INC LB PHARMACEUTICALS INC COM SHS | US50180M1080 | 50180M108 | 0.945% | $438K | Equity (common) | Corporate | United States | USD |
| 14 | DAMORA THERAPEUTICS INC DAMORA THERAPEUTICS INC COM USD0.00001 | KYG2646Y1044 | Not reported | 0.935% | $434K | Equity (common) | Corporate | Cayman Islands | USD |
| 15 | AMYLYX PHARMACEUTICALS INC AMYLYX PHARMACEUTICALS INC COM | US03237H1014 | 03237H101 | 0.933% | $433K | Equity (common) | Corporate | United States | USD |
| 16 | DYNE THERAPEUTICS INC DYNE THERAPEUTICS INC COM | US26818M1080 | 26818M108 | 0.927% | $430K | Equity (common) | Corporate | United States | USD |
| 17 | ORUKA THERAPEUTICS INC ORUKA THERAPEUTICS INC COM | US6876041087 | 687604108 | 0.925% | $429K | Equity (common) | Corporate | United States | USD |
| 18 | NURIX THERAPEUTICS INC NURIX THERAPEUTICS INC COM | US67080M1036 | 67080M103 | 0.917% | $426K | Equity (common) | Corporate | United States | USD |
| 19 | ORIC PHARMACEUTICALS INC ORIC PHARMACEUTICALS INC COM | US68622P1093 | 68622P109 | 0.897% | $416K | Equity (common) | Corporate | United States | USD |
| 20 | GH RESEARCH PLC GH RESEARCH PLC ORDINARY SHARES | IE000GID8VI0 | Not reported | 0.890% | $413K | Equity (common) | Corporate | Ireland | USD |
| 21 | SIONNA THERAPEUTICS INC SIONNA THERAPEUTICS INC COM | US8294011080 | 829401108 | 0.879% | $408K | Equity (common) | Corporate | United States | USD |
| 22 | DIANTHUS THERAPEUTICS INC DIANTHUS THERAPEUTICS INC COM | US2528281080 | 252828108 | 0.873% | $405K | Equity (common) | Corporate | United States | USD |
| 23 | ERASCA INC ERASCA INC COM | US29479A1088 | 29479A108 | 0.865% | $402K | Equity (common) | Corporate | United States | USD |
| 24 | JADE BIOSCIENCES INC JADE BIOSCIENCES INC COM NEW | US0080642061 | 008064206 | 0.863% | $400K | Equity (common) | Corporate | United States | USD |
| 25 | SELLAS LIFE SCIENCES GROUP INC SELLAS LIFE SCIENCES GROUP INC COM NEW | US81642T2096 | 81642T209 | 0.856% | $397K | Equity (common) | Corporate | United States | USD |
| 26 | PALVELLA THERAPEUTICS INC PALVELLA THERAPEUTICS INC COM | US6979471090 | 697947109 | 0.856% | $397K | Equity (common) | Corporate | United States | USD |
| 27 | RELAY THERAPEUTICS INC RELAY THERAPEUTICS INC COM | US75943R1023 | 75943R102 | 0.852% | $395K | Equity (common) | Corporate | United States | USD |
| 28 | REPLIMUNE GROUP INC REPLIMUNE GROUP INC COM | US76029N1063 | 76029N106 | 0.845% | $392K | Equity (common) | Corporate | United States | USD |
| 29 | ALTO NEUROSCIENCE INC ALTO NEUROSCIENCE INC COM SHS | US02157Q1094 | 02157Q109 | 0.845% | $392K | Equity (common) | Corporate | United States | USD |
| 30 | ADLAI NORTYE LTD ADLAI NORTYE LTD SPONSORED ADS | US00704R1095 | 00704R109 | 0.844% | $392K | Equity (common) | Corporate | Cayman Islands | USD |
| 31 | BICARA THERAPEUTICS INC BICARA THERAPEUTICS INC COM | US0554771032 | 055477103 | 0.837% | $388K | Equity (common) | Corporate | United States | USD |
| 32 | IMMUNOME INC IMMUNOME INC COM | US45257U1088 | 45257U108 | 0.830% | $385K | Equity (common) | Corporate | United States | USD |
| 33 | AVALO THERAPEUTICS INC AVALO THERAPEUTICS INC COM NEW | US05338F3064 | 05338F306 | 0.828% | $384K | Equity (common) | Corporate | United States | USD |
| 34 | MEIRAGTX HOLDINGS PLC MEIRAGTX HOLDINGS PLC COM | KYG596651029 | Not reported | 0.824% | $382K | Equity (common) | Corporate | Cayman Islands | USD |
| 35 | IDEAYA BIOSCIENCES INC IDEAYA BIOSCIENCES INC COM | US45166A1025 | 45166A102 | 0.821% | $381K | Equity (common) | Corporate | United States | USD |
| 36 | SPYGLASS PHARMA INC SPYGLASS PHARMA INC COM SHS | US85220G1094 | 85220G109 | 0.819% | $380K | Equity (common) | Corporate | United States | USD |
| 37 | KODIAK SCIENCES INC KODIAK SCIENCES INC COM | US50015M1099 | 50015M109 | 0.818% | $379K | Equity (common) | Corporate | United States | USD |
| 38 | REVOLUTION MEDICINES INC REVOLUTION MEDICINES INC COM | US76155X1000 | 76155X100 | 0.817% | $379K | Equity (common) | Corporate | United States | USD |
| 39 | CELLDEX THERAPEUTICS INC CELLDEX THERAPEUTICS INC COM NEW | US15117B2025 | 15117B202 | 0.815% | $378K | Equity (common) | Corporate | United States | USD |
| 40 | SPYRE THERAPEUTICS INC SPYRE THERAPEUTICS INC COM NEW | US00773J2024 | 00773J202 | 0.815% | $378K | Equity (common) | Corporate | United States | USD |
| 41 | CULLINAN THERAPEUTICS INC CULLINAN THERAPEUTICS INC COM | US2300311063 | 230031106 | 0.807% | $374K | Equity (common) | Corporate | United States | USD |
| 42 | LEXICON PHARMACEUTICALS INC LEXICON PHARMACEUTICALS INC COM NEW | US5288723027 | 528872302 | 0.806% | $374K | Equity (common) | Corporate | United States | USD |
| 43 | XENON PHARMACEUTICALS INC XENON PHARMACEUTICALS INC COM | CA98420N1050 | 98420N105 | 0.806% | $374K | Equity (common) | Corporate | Canada | USD |
| 44 | KYMERA THERAPEUTICS INC KYMERA THERAPEUTICS INC COM | US5015751044 | 501575104 | 0.803% | $373K | Equity (common) | Corporate | United States | USD |
| 45 | BIOHAVEN LTD BIOHAVEN LTD COM | VGG1110E1079 | Not reported | 0.802% | $372K | Equity (common) | Corporate | British Virgin Islands | USD |
| 46 | CG ONCOLOGY INC CG ONCOLOGY INC COM | US1569441009 | 156944100 | 0.801% | $371K | Equity (common) | Corporate | United States | USD |
| 47 | NEKTAR THERAPEUTICS NEKTAR THERAPEUTICS COM NEW | US6402683063 | 640268306 | 0.797% | $370K | Equity (common) | Corporate | United States | USD |
| 48 | ENLIVEN THERAPEUTICS INC ENLIVEN THERAPEUTICS INC COM | US29337E1029 | 29337E102 | 0.796% | $369K | Equity (common) | Corporate | United States | USD |
| 49 | ARCUS BIOSCIENCES INC ARCUS BIOSCIENCES INC COM | US03969F1093 | 03969F109 | 0.794% | $368K | Equity (common) | Corporate | United States | USD |
| 50 | TYRA BIOSCIENCES INC TYRA BIOSCIENCES INC COM | US90240B1061 | 90240B106 | 0.791% | $367K | Equity (common) | Corporate | United States | USD |
| 51 | REZOLUTE INC REZOLUTE INC COM NEW | US76200L3096 | 76200L309 | 0.791% | $367K | Equity (common) | Corporate | United States | USD |
| 52 | COGENT BIOSCIENCES INC COGENT BIOSCIENCES INC COM | US19240Q2012 | 19240Q201 | 0.788% | $366K | Equity (common) | Corporate | United States | USD |
| 53 | ALUMIS INC ALUMIS INC COM | US0223071020 | 022307102 | 0.784% | $364K | Equity (common) | Corporate | United States | USD |
| 54 | CANDEL THERAPEUTICS INC CANDEL THERAPEUTICS INC COM | US1374041093 | 137404109 | 0.783% | $363K | Equity (common) | Corporate | United States | USD |
| 55 | SANA BIOTECHNOLOGY INC SANA BIOTECHNOLOGY INC COM | US7995661045 | 799566104 | 0.782% | $363K | Equity (common) | Corporate | United States | USD |
| 56 | ACHIEVE LIFE SCIENCES INC ACHIEVE LIFE SCIENCES INC COM | US0044685008 | 004468500 | 0.779% | $361K | Equity (common) | Corporate | United States | USD |
| 57 | OLEMA PHARMACEUTICALS INC OLEMA PHARMACEUTICALS INC COM | US68062P1066 | 68062P106 | 0.777% | $361K | Equity (common) | Corporate | United States | USD |
| 58 | VIRIDIAN THERAPEUTICS INC VIRIDIAN THERAPEUTICS INC COM | US92790C1045 | 92790C104 | 0.775% | $360K | Equity (common) | Corporate | United States | USD |
| 59 | PRAXIS PRECISION MEDICINES INC PRAXIS PRECISION MEDICINES INC COM NEW | US74006W2070 | 74006W207 | 0.774% | $359K | Equity (common) | Corporate | United States | USD |
| 60 | 4D MOLECULAR THERAPEUTICS INC 4D MOLECULAR THERAPEUTICS INC COM | US35104E1001 | 35104E100 | 0.772% | $358K | Equity (common) | Corporate | United States | USD |
| 61 | IMMUNOVANT INC IMMUNOVANT INC COM | US45258J1025 | 45258J102 | 0.770% | $357K | Equity (common) | Corporate | United States | USD |
| 62 | BELITE BIO INC BELITE BIO INC SPONSORED ADS | US07782B1044 | 07782B104 | 0.769% | $357K | Equity (common) | Corporate | Cayman Islands | USD |
| 63 | VAXCYTE INC VAXCYTE INC COM | US92243G1085 | 92243G108 | 0.763% | $354K | Equity (common) | Corporate | United States | USD |
| 64 | DISC MEDICINE INC DISC MEDICINE INC COM | US2546041011 | 254604101 | 0.759% | $352K | Equity (common) | Corporate | United States | USD |
| 65 | ROCKET PHARMACEUTICALS INC ROCKET PHARMACEUTICALS INC COM | US77313F1066 | 77313F106 | 0.758% | $352K | Equity (common) | Corporate | United States | USD |
| 66 | GENERATE BIOMEDICINES INC GENERATE BIOMEDICINES INC COM SHS | US3709201004 | 370920100 | 0.758% | $351K | Equity (common) | Corporate | United States | USD |
| 67 | NEUROGENE INC NEUROGENE INC COM | US64135M1053 | 64135M105 | 0.757% | $351K | Equity (common) | Corporate | United States | USD |
| 68 | SOLID BIOSCIENCES INC SOLID BIOSCIENCES INC COM NEW | US83422E2046 | 83422E204 | 0.756% | $351K | Equity (common) | Corporate | United States | USD |
| 69 | MAZE THERAPEUTICS INC MAZE THERAPEUTICS INC COM | US5787841007 | 578784100 | 0.750% | $348K | Equity (common) | Corporate | United States | USD |
| 70 | STRUCTURE THERAPEUTICS INC STRUCTURE THERAPEUTICS INC SPONSORED ADS | US86366E1064 | 86366E106 | 0.750% | $348K | Equity (common) | Corporate | Cayman Islands | USD |
| 71 | JANUX THERAPEUTICS INC JANUX THERAPEUTICS INC COM | US47103J1051 | 47103J105 | 0.750% | $348K | Equity (common) | Corporate | United States | USD |
| 72 | CORVUS PHARMACEUTICALS INC CORVUS PHARMACEUTICALS INC COM | US2210151005 | 221015100 | 0.745% | $345K | Equity (common) | Corporate | United States | USD |
| 73 | DESIGN THERAPEUTICS INC DESIGN THERAPEUTICS INC COM | US25056L1035 | 25056L103 | 0.744% | $345K | Equity (common) | Corporate | United States | USD |
| 74 | VIKING THERAPEUTICS INC VIKING THERAPEUTICS INC COM | US92686J1060 | 92686J106 | 0.740% | $343K | Equity (common) | Corporate | United States | USD |
| 75 | EDGEWISE THERAPEUTICS INC EDGEWISE THERAPEUTICS INC COM | US28036F1057 | 28036F105 | 0.739% | $343K | Equity (common) | Corporate | United States | USD |
| 76 | AURA BIOSCIENCES INC AURA BIOSCIENCES INC COM | US05153U1079 | 05153U107 | 0.733% | $340K | Equity (common) | Corporate | United States | USD |
| 77 | ASSEMBLY BIOSCIENCES INC ASSEMBLY BIOSCIENCES INC COM NEW | US0453962070 | 045396207 | 0.733% | $340K | Equity (common) | Corporate | United States | USD |
| 78 | VERADERMICS INC VERADERMICS INC COMMON STOCK | US9229671048 | 922967104 | 0.732% | $340K | Equity (common) | Corporate | United States | USD |
| 79 | ABCELLERA BIOLOGICS INC ABCELLERA BIOLOGICS INC COM | CA00288U1066 | 00288U106 | 0.730% | $339K | Equity (common) | Corporate | Canada | USD |
| 80 | ALTIMMUNE INC ALTIMMUNE INC COM NEW | US02155H2004 | 02155H200 | 0.729% | $338K | Equity (common) | Corporate | United States | USD |
| 81 | ANNEXON INC ANNEXON INC COM | US03589W1027 | 03589W102 | 0.725% | $336K | Equity (common) | Corporate | United States | USD |
| 82 | MINERALYS THERAPEUTICS INC MINERALYS THERAPEUTICS INC COM | US6031701013 | 603170101 | 0.724% | $336K | Equity (common) | Corporate | United States | USD |
| 83 | SCHOLAR ROCK HOLDING CORP SCHOLAR ROCK HOLDING CORP COM | US80706P1030 | 80706P103 | 0.717% | $333K | Equity (common) | Corporate | United States | USD |
| 84 | RAPPORT THERAPEUTICS INC RAPPORT THERAPEUTICS INC COM | US75383L1026 | 75383L102 | 0.715% | $332K | Equity (common) | Corporate | United States | USD |
| 85 | PHARVARIS NV PHARVARIS NV COM | NL00150005Y4 | Not reported | 0.711% | $330K | Equity (common) | Corporate | Netherlands | USD |
| 86 | ARVINAS INC ARVINAS INC COM | US04335A1051 | 04335A105 | 0.710% | $329K | Equity (common) | Corporate | United States | USD |
| 87 | PRIME MEDICINE INC PRIME MEDICINE INC COM | US74168J1016 | 74168J101 | 0.705% | $327K | Equity (common) | Corporate | United States | USD |
| 88 | BRIDGEBIO ONCOLOGY THERAPEUTICS INC BRIDGEBIO ONCOLOGY THERAPEUTICS INC COM NEW | US1079241022 | 107924102 | 0.699% | $324K | Equity (common) | Corporate | United States | USD |
| 89 | CLIMB BIO INC CLIMB BIO INC COM | US28658R1068 | 28658R106 | 0.697% | $323K | Equity (common) | Corporate | United States | USD |
| 90 | SAVARA INC SAVARA INC COM | US8051111016 | 805111101 | 0.695% | $323K | Equity (common) | Corporate | United States | USD |
| 91 | UPSTREAM BIO INC UPSTREAM BIO INC COM | US91678A1079 | 91678A107 | 0.693% | $322K | Equity (common) | Corporate | United States | USD |
| 92 | CYTOMX THERAPEUTICS INC CYTOMX THERAPEUTICS INC COM | US23284F1057 | 23284F105 | 0.690% | $320K | Equity (common) | Corporate | United States | USD |
| 93 | TAYSHA GENE THERAPIES INC TAYSHA GENE THERAPIES INC COM SHS | US8776191061 | 877619106 | 0.688% | $319K | Equity (common) | Corporate | United States | USD |
| 94 | OCULIS HOLDING AG OCULIS HOLDING AG ORDINARY SHARES | CH1242303498 | Not reported | 0.683% | $317K | Equity (common) | Corporate | Switzerland | USD |
| 95 | ARBUTUS BIOPHARMA CORP ARBUTUS BIOPHARMA CORP COM | CA03879J1003 | 03879J100 | 0.683% | $317K | Equity (common) | Corporate | Canada | USD |
| 96 | AKTIS ONCOLOGY INC AKTIS ONCOLOGY INC COM | US01021M1045 | 01021M104 | 0.674% | $313K | Equity (common) | Corporate | United States | USD |
| 97 | VIR BIOTECHNOLOGY INC VIR BIOTECHNOLOGY INC COM | US92764N1028 | 92764N102 | 0.674% | $313K | Equity (common) | Corporate | United States | USD |
| 98 | ALLOGENE THERAPEUTICS INC ALLOGENE THERAPEUTICS INC COM | US0197701065 | 019770106 | 0.663% | $308K | Equity (common) | Corporate | United States | USD |
| 99 | MOONLAKE IMMUNOTHERAPEUTICS MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | KY61559X1045 | 61559X104 | 0.661% | $307K | Equity (common) | Corporate | Cayman Islands | USD |
| 100 | IMMIX BIOPHARMA INC IMMIX BIOPHARMA INC COM | US45258H1068 | 45258H106 | 0.660% | $306K | Equity (common) | Corporate | United States | USD |